Ontology highlight
ABSTRACT:
SUBMITTER: Sellem B
PROVIDER: S-EPMC10145141 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature
Sellem Baptiste B Abdi Basma B Lê Minh M Tubiana Roland R Valantin Marc-Antoine MA Seang Sophie S Schneider Luminita L Fayçal Antoine A Peytavin Gilles G Soulié Cathia C Marcelin Anne-Geneviève AG Katlama Christine C Pourcher Valérie V Palich Romain R
Journal of personalized medicine 20230327 4
In this observational study, we aimed to evaluate whether bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) administered 5 or 4 days a week is able to maintain viral suppression in people living with HIV (PLHIV). We enrolled 85 patients who initiated intermittent B/F/TAF between 28 November 2018 and 30 July 2020: median (IQR) age 52 years (46-59), duration of virological suppression 9 years (3-13), CD4 633/mm<sup>3</sup> (461-781). Median follow-up was 101 weeks (82-111). The virological ...[more]